[The efficacy of treating patients with intraocular hemorrhages with emoxypin].
Emoxipin, a home-made preparation approved by the Pharmacological Committee for clinical usage in 1986, is a retinal protector. Its usage is indicated for treatment of chorioretinitis, diabetic retinopathy, thrombosis of retinal vessels as well as to protects the retina from a damaging action of light of high intensity. In order to study therapeutic effectiveness of emoxipin in intraocular hemorrhages of different genesis, the preparation was used subconjunctivally, 0.5 ml of a 1% solution daily for 10-15 days. Emoxipin was used in 29 patients (29 eyes) with intraocular hemorrhages, of them, due to contusion of the eye--in 19, hypertonic disease--in 6, thrombosis of the central retinal vein--in 2, after intraocular operations--in 2 patients. As a result of the treatment, partial or almost total resolution of hemorrhages and a rise of visual acuity of different degree were recorded in all patients. Before treatment, visual acuity was from light perception to 0.04 in 26 eyes, from 0.09 to 0.3 in 3 eyes. After treatment, it rose to 0.1-0.2 in 12 eyes, to 0.3-1.0--in 17 eyes.
Mokhammad
I
I
Cherkasov
I S
IS
D000293:Adolescent; D000328:Adult; D002648:Child; D004341:Drug Evaluation; D005130:Eye Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D010847:Picolines / Q000627:therapeutic use*; D014792:Visual Acuity / Q000187:drug effects
D010847:Picolines; C009820:6-methyl-2-ethyl-3-hydroxypyridine
Effektivnost' lecheniia bol'nykh s vnutriglaznymi krovoizliianiiami émoksipinom.